MMP2 and myocardial infarction: Meanwhile, compared to the MI-N.S heart, the expression of fibrosis markers including collagen III (COL III) and matrix metalloproteinase 2 (MMP2) significantly decreased in the MI heart treated with HucMSCs on day 28 (Fig. 4F).